Treatment of dyslipidemia in patients with type 2 diabetes: Overview and meta-analysis of randomized trials

Based on the above-mentioned evidence, all patients with diabetes should be treated with statins to achieve LDL cholesterol level ≤2.0 mmol/l. A secondary goal of triglyceride level ≤1.5 mmol/l is also reasonable to achieve. Achieving of both goals may warrant combination of statin treatment with fibrate, ezetimibe or niacin. However, results of no endpoint study with lipid lowering combination treatment have been published thus far.